Hello, Guest!
 
 

🔍
REVIEW

Description

Al222
Al222 (25122 pt) 2025-Nov-15 11:20

Pyrophosphate
(group of diphosphate salts used as food additives, e.g. disodium diphosphate / sodium acid pyrophosphate and tetrasodium diphosphate — E450)


Description

  • Pyrophosphate in food usually refers to a group of condensed phosphate salts (diphosphates) containing the pyrophosphate anion (P₂O₇⁴⁻), most commonly:

    • Disodium diphosphate / sodium acid pyrophosphate (SAPP, E450(i))

    • Tetrasodium diphosphate / tetrasodium pyrophosphate (TSPP, E450(iii)) 

  • Supplied as a white, odourless, crystalline or powdery solid, highly soluble in water; solutions are acidic (SAPP) or alkaline (TSPP). 

  • Used in foods as leavening acids, buffering agents, sequestrants/chelators, emulsifiers, and water-binding / texture modifiers in many processed products (bakery, meats, seafood, potato products, processed cheese, puddings). 


Key constituents

  • Pyrophosphate anion (P₂O₇⁴⁻):

    • Formed by condensation of two orthophosphate units; strong affinity for multivalent cations (Ca²⁺, Fe³⁺, Mg²⁺). 

    • Acts as a chelating/sequestering agent and pH buffer.

  • Counter-ions (Na⁺, K⁺, etc.):

    • Define solubility, pH and functionality (e.g. tetrasodium vs tetrapotassium pyrophosphate).

  • No proteins, lipids, vitamins or organic carbohydrates: function is technological, not nutritional.


Production process

  • Pyrophosphate salts are typically produced in two main steps:

    1. Preparation of orthophosphate salts

      • Neutralisation of food-grade phosphoric acid with sodium or potassium carbonate/hydroxide to form disodium phosphate or related orthophosphates. 

    2. Thermal condensation

      • Heating the orthophosphate at elevated temperature (e.g. around 450 °C for sodium salts) to form pyrophosphate and water:

        • 2 Na₂HPO₄ → Na₄P₂O₇ + H₂O (TSPP) 

        • NaH₂PO₄ → Na₂H₂P₂O₇ + H₂O (SAPP-like) 

  • The crude salt is then milled, sieved and standardised, ensuring food-grade purity (heavy metals, insolubles, etc.) according to standards (FCC, EU, GB, etc.). 


Physical properties

  • Appearance: white crystalline powder or granules, free-flowing if properly dried. 

  • Odour: odourless

  • Solubility: freely soluble in water; insoluble in ethanol; solubility increases with temperature. 

  • pH (1% solutions):

    • SAPP: slightly acidic (typically pH ~4.0–4.5 depending on grade). 

    • TSPP: alkaline (pH ~9.8–10.8). 

  • Hygroscopicity: can absorb moisture and cake or partially deliquesce if exposed to high humidity. 

  • Thermal behaviour: stable at normal processing temperatures; at very high temperatures can further condense or degrade.


Sensory and technological properties

  • Direct flavour impact at normal levels is minimal; high dosages can create salty, soapy or slightly bitter/metallic notes (especially SAPP). 

  • Leavening function (SAPP):

    • Reacts with sodium bicarbonate to release CO₂ in batters and doughs; different SAPP grades give fast or slow reaction profiles (dual-action baking powders). 

  • Chelation and colour control:

    • Binds iron and other metals, preventing greying/darkening in potato products (fries, hash browns) and stabilising canned seafood colour. 

  • Protein functionality (especially TSPP):

    • Enhances water-holding capacity, gelation and texture in meats, seafood and meat analogues; reduces cooking loss and improves sliceability. 

  • Buffering and emulsification:

    • Helps stabilise pH, emulsions and dispersions in processed cheese, puddings, sauces and beverages. 


Food applications

  • Bakery

    • SAPP as a chemical leavening acid in baking powders, cake mixes, pancake mixes, biscuits and muffins.

  • Potato and vegetable products

    • Frozen fries, hash browns, dehydrated potatoes: prevents enzymatic/non-enzymatic browning and stabilises colour during processing and storage. 

  • Meat and poultry

    • Cured and cooked sausages, hams, nuggets: improves water retention, texture and slicing; SAPP can also act as curing accelerator (colour development with nitrite).

  • Seafood

    • Canned tuna, crab, imitation crab and shrimp: maintains colour, reduces purge and improves juiciness.

  • Processed cheese and dairy

    • TSPP and other diphosphates as emulsifying salts in processed cheese, cheese spreads, instant puddings. 

  • Beverages and powders

    • Powdered drinks, cocoa mixes, nutritional powders: pH control, dispersion aid, sometimes part of mineral premixes.


Nutrition & health

  • Pyrophosphate salts have no direct macronutrient value (no protein, fat, carbohydrate), but they provide phosphorus and sodium/potassium.

  • Major health discussion points relate to total dietary phosphate load, not to energy or fats:

    • Phosphate additives, including diphosphates (E450), contribute to total phosphorus intake on top of natural phosphorus in foods. 

    • High phosphate intake has been associated with potential concerns for kidney function, bone health and cardiovascular risk, especially in people with chronic kidney disease (CKD) or impaired phosphate excretion. This is why authorities have set a group ADI for phosphates and continue to monitor exposure. 

  • Toxicological evaluations by JECFA, EFSA and FDA have concluded that pyrophosphates are acceptable for food use at authorised levels; experimental high-dose animal studies show haematological or immune effects far above normal dietary exposures. 

  • For the general public, occasional consumption of products containing E450 within regulatory limits is considered safe; for individuals with CKD or conditions requiring phosphate restriction, total intake from diet (including additives) should be carefully controlled in consultation with healthcare professionals.

Serving note: Typical use levels are on the order of 0.1–0.5% in many foods; this corresponds to tens to a few hundred milligrams per portion, depending on product type and serving size.


Allergens and intolerances

  • Pyrophosphate salts do not contain proteins and are not major allergens.

  • Hypersensitivity or intolerance is rare, but some individuals may report non-specific reactions to phosphate additives or high-phosphate diets.

  • The main medical concern is phosphate load in people with renal disease or severe mineral metabolism disorders, not classical allergy.

  • Co-formulated products (meat products, processed cheese, bakery) may contain other allergens (milk, gluten, soy, eggs, etc.) that are unrelated to the pyrophosphate itself.


Quality and specifications (typical themes)

  • Chemical

    • Assay (minimum % of pyrophosphate salt on dry basis).

    • Limits for orthophosphate, triphosphates and higher polyphosphates.

    • Sodium/potassium content within specified range; pH of defined solution. 

  • Purity

    • Heavy metals (Pb, Cd, Hg, As) below strict limits.

    • Low insoluble matter, low fluoride (where specified).

  • Physical

    • Moisture content; particle size distribution; bulk density; flowability.

    • Caking tendency monitored and managed by packaging and handling.

  • Microbiology

    • As an inorganic dry salt, intrinsic microbiological risk is low; typical specs limit total plate count and ensure absence of pathogens in powder.


Storage and shelf-life

  • Store in a cool, dry place, away from moisture and strong odours.

  • Keep in sealed moisture-barrier packaging (multi-layer bags, lined sacks, big bags).

  • Avoid high humidity to prevent caking/deliquescence and maintain free-flowing properties. 

  • Typical shelf-life: 24 months in unopened original packaging under recommended conditions, with periodic re-testing for older stock. 


Safety and regulatory

  • In the EU and many other jurisdictions, pyrophosphate salts are authorised as food additives E450 (diphosphates):

    • E450(i) disodium diphosphate (sodium acid pyrophosphate, SAPP)

    • E450(iii) tetrasodium diphosphate (TSPP)

    • and related sodium/potassium forms. 

  • Recognised as GRAS (Generally Recognised As Safe) for specified uses in the USA when used according to good manufacturing practice. 

  • Subject to maximum permitted levels and quantum satis conditions depending on food category; exposure is assessed on a phosphate-group basis (E338–341, 343, 450–452). 

  • Production and use must follow GMP/HACCP, with traceability of batches, raw materials and processing conditions.


Labeling

  • On ingredient lists, pyrophosphate salts may appear as:

    • disodium diphosphate”, “sodium acid pyrophosphate”, “tetrasodium diphosphate”, “tetrasodium pyrophosphate”, etc.

    • or as “E450” with a letter/roman numeral suffix (e.g. “E450(i)”). 

  • In some markets, the functional class is also indicated, e.g. “emulsifying salt (E450)”, “raising agent (E450)”, “sequestrant (E450)”.

  • Products must also comply with any nutrient claim rules (e.g. claims related to sodium or phosphorus) if such claims are made.


Troubleshooting

  • Soapy or bitter off-taste in finished products

    • Cause: excessive pyrophosphate level or unbalanced formula (especially in bakery or processed meats).

    • Action: reduce dosage, rebalance salt/sugar, combine with other leavening acids or phosphates, adjust flavour profile.

  • Too fast or too slow leavening (cakes, muffins)

    • Cause: inappropriate SAPP grade or wrong ratio of SAPP to sodium bicarbonate.

    • Action: select correct reactivity grade, fine-tune acid–base balance and batter temperature profile. 

  • Soft, mushy texture / excessive water retention in meats or seafood

    • Cause: overdosing TSPP or combined phosphates, leading to too high WHC.

    • Action: reduce phosphate dosage, adjust ionic strength, salt and protein level, and cooking conditions. 

  • Poor colour stability in potatoes

    • Cause: insufficient SAPP or inadequate contact time/pH; metal content in water too high.

    • Action: optimise SAPP level and dip/contact conditions; consider water quality and other antioxidants. 


Sustainability and supply chain

  • Pyrophosphate salts originate from phosphate rock via phosphoric acid and downstream neutralisation/condensation; sustainability concerns relate to:

    • finite phosphate reserves,

    • environmental impacts of mining and phosphoric acid manufacture.

  • In food use, the quantities are relatively small, but the phosphate content in effluents from food and detergent use can contribute to eutrophication if wastewater is not adequately treated. 

  • Good practice includes:

    • optimising dosing in formulations (no over-use),

    • efficient wastewater treatment (nutrient removal, BOD/COD reduction),

    • responsible sourcing of phosphates and using FIFO for stock to avoid expired/wasted chemicals.


Main INCI functions (cosmetics)

  • Common cosmetic/INCI names: Tetrasodium Pyrophosphate, Disodium Pyrophosphate, Tetrapotassium Pyrophosphate, etc.

  • Functions:

    • Chelating agent (binds metal ions, improving product stability and preservative performance),

    • Buffering agent (pH adjustment),

    • Tartar-control agent in toothpaste and mouthwash (binding calcium and magnesium, reducing calculus). 

  • Cosmetic-grade material must meet stricter specifications on purity and contaminants compared with technical or generic food-grade products.


Conclusion

As food ingredients, pyrophosphate salts (diphosphates, E450) form a versatile toolbox of inorganic functional agents. They contribute leavening, pH control, chelation, water binding and texture in bakery, meat, seafood, potato and dairy products, with negligible impact on calories and fat. Their main nutritional relevance lies in phosphate and sodium/potassium load, which is acceptable for most consumers at authorised levels but requires attention in specific health conditions such as chronic kidney disease. When used within regulatory limits and managed under robust GMP/HACCP and environmental controls, pyrophosphates are effective, reliable and widely adopted functional ingredients in modern food processing.


Mini-glossary

  • SFA/MUFA/PUFA – Saturated/monounsaturated/polyunsaturated fatty acids; pyrophosphate salts do not contain fats, but in general it is advisable that diets keep saturated fat (SFA) moderate and favour unsaturated fats for cardiometabolic health.

  • Chelating/sequestrant – Substance that binds metal ions (Ca²⁺, Fe³⁺, etc.), reducing their reactivity; in foods, this helps prevent oxidation and colour changes and can modify texture.

  • SAPP (sodium acid pyrophosphate) – Disodium dihydrogen diphosphate, a common pyrophosphate used mainly as a leavening acid and sequestrant.

  • TSPP (tetrasodium pyrophosphate) – Tetrasodium diphosphate, used to adjust pH, bind water and improve texture in meat, seafood and processed cheese.

  • GMP/HACCP – Good Manufacturing Practices / Hazard Analysis and Critical Control Points; core systems for hygienic, safe and traceable food production.

  • BOD/COD – Biochemical/Chemical Oxygen Demand; indicators of organic (and oxidisable) load in wastewater, used to design and monitor effluent treatment; phosphates themselves mainly contribute to eutrophication and nutrient load alongside organic matter.

  • FIFO – First In, First Out; stock rotation principle ensuring that older batches are used before newer ones, reducing waste and quality loss over time.

References__________________________________________________________________________

Villa-Bellosta R. Vascular Calcification: Key Roles of Phosphate and Pyrophosphate. Int J Mol Sci. 2021 Dec 17;22(24):13536. doi: 10.3390/ijms222413536. 

Abstract. Cardiovascular complications due to accelerated arterial stiffening and atherosclerosis are the leading cause of morbimortality in Western society. Both pathologies are frequently associated with vascular calcification. Pathologic calcification of cardiovascular structures, or vascular calcification, is associated with several diseases (for example, genetic diseases, diabetes, and chronic kidney disease) and is a common consequence of aging. Calcium phosphate deposition, mainly in the form of hydroxyapatite, is the hallmark of vascular calcification and can occur in the medial layer of arteries (medial calcification), in the atheroma plaque (intimal calcification), and cardiac valves (heart valve calcification). Although various mechanisms have been proposed for the pathogenesis of vascular calcification, our understanding of the pathogenesis of calcification is far from complete. However, in recent years, some risk factors have been identified, including high serum phosphorus concentration (hyperphosphatemia) and defective synthesis of pyrophosphate (pyrophosphate deficiency). The balance between phosphate and pyrophosphate, strictly controlled by several genes, plays a key role in vascular calcification. This review summarizes the current knowledge concerning phosphate and pyrophosphate homeostasis, focusing on the role of extracellular pyrophosphate metabolism in aortic smooth muscle cells and macrophages.

Zimmermann MB, Biebinger R, Egli I, Zeder C, Hurrell RF. Iron deficiency up-regulates iron absorption from ferrous sulphate but not ferric pyrophosphate and consequently food fortification with ferrous sulphate has relatively greater efficacy in iron-deficient individuals. Br J Nutr. 2011 Apr;105(8):1245-50. doi: 10.1017/S0007114510004903. 

Abstract. Fe absorption from water-soluble forms of Fe is inversely proportional to Fe status in humans. Whether this is true for poorly soluble Fe compounds is uncertain. Our objectives were therefore (1) to compare the up-regulation of Fe absorption at low Fe status from ferrous sulphate (FS) and ferric pyrophosphate (FPP) and (2) to compare the efficacy of FS with FPP in a fortification trial to increase body Fe stores in Fe-deficient children v. Fe-sufficient children. Using stable isotopes in test meals in young women (n 49) selected for low and high Fe status, we compared the absorption of FPP with FS. We analysed data from previous efficacy trials in children (n 258) to determine whether Fe status at baseline predicted response to FS v. FPP as salt fortificants. Plasma ferritin was a strong negative predictor of Fe bioavailability from FS (P < 0·0001) but not from FPP. In the efficacy trials, body Fe at baseline was a negative predictor of the change in body Fe for both FPP and FS, but the effect was significantly greater with FS (P < 0·01). Because Fe deficiency up-regulates Fe absorption from FS but not from FPP, food fortification with FS may have relatively greater impact in Fe-deficient children. Thus, more soluble Fe compounds not only demonstrate better overall absorption and can be used at lower fortification levels, but they also have the added advantage that, because their absorption is up-regulated in Fe deficiency, they innately 'target' Fe-deficient individuals in a population.

Moretti D, Zimmermann MB, Wegmüller R, Walczyk T, Zeder C, Hurrell RF. Iron status and food matrix strongly affect the relative bioavailability of ferric pyrophosphate in humans. Am J Clin Nutr. 2006 Mar;83(3):632-8. doi: 10.1093/ajcn.83.3.632. 

Abstract. Background: Although ferric pyrophosphate is a promising compound for iron fortification of foods, few data are available on the effect of food matrices, processing, and ascorbic acid on its bioavailability. Objective: We compared the relative bioavailability (RBV) of ferrous sulfate in an experimental form of micronized dispersible ferric pyrophosphate (MDFP) in a wheat-milk infant cereal given with and without ascorbic acid with the RBV of MDFP from a processed and unprocessed rice meal. Design: A crossover design was used to measure iron absorption in young women (n = 26) from test meals fortified with isotopically labeled [57Fe]-MDFP and [58Fe]-ferrous sulfate, based on erythrocyte incorporation of stable isotope labels 14 d later. Results: Geometric mean iron absorption from the wheat-based meal fortified with MDFP was 2.0% and that from the meal fortified with ferrous sulfate was 3.2% (RBV = 62). The addition of ascorbic acid at a molar ratio of 4:1 to iron increased iron absorption from MDFP to 5.8% and that from ferrous sulfate to 14.8% (RBV = 39). In the rice meals, mean iron absorption from MDFP added to the rice at the time of feeding was 1.7%, and that from ferrous sulfate was 11.6% (RBV = 15). The mean iron absorption from MDFP extruded into artificial rice grains was 3.0% and that from ferrous sulfate in unprocessed rice was 12.6% (RBV = 24). Sixteen of 26 subjects were iron deficient. Iron status was a highly significant predictor of the RBV of MDFP (P < 0.001). Conclusion: RBV of the experimental MDFP varied markedly with food matrix and iron status. Assigning a single RBV value to poorly soluble compounds may be of limited value in evaluating their suitability for food fortification.

Gupta A, Pratt R, Mishra B. Physicochemical characterization of ferric pyrophosphate citrate. Biometals. 2018 Dec;31(6):1091-1099. doi: 10.1007/s10534-018-0151-1. 

Abstract. Iron deficiency is a significant health problem across the world. While many patients benefit from oral iron supplements, some, including those on hemodialysis require intravenous iron therapy to maintain adequate iron levels. Until recently, all iron compounds suitable for parenteral administration were colloidal iron-carbohydrate conjugates that require uptake and processing by macrophages. These compounds are associated with variable risk of anaphylaxis, oxidative stress, and inflammation, depending on their physicochemical characteristics. Ferric pyrophosphate citrate (FPC) is a novel iron compound that was approved for parenteral administration by US Food and Drug Administration in 2015. Here we report the physicochemical characteristics of FPC. FPC is a noncolloidal, highly water soluble, complex iron salt that does not contain a carbohydrate moiety. X-ray absorption spectroscopy data indicate that FPC consists of iron (III) complexed with one pyrophosphate and two citrate molecules in the solid state. This structure is preserved in solution and stable for several months, rendering it suitable for pharmaceutical applications in solid or solution state.

Salgueiro MJ, Arnoldi S, Kaliski MA, Torti H, Messeri E, Weill R, Zubillaga M, Boccio J. Stabilized-solubilized ferric pyrophosphate as a new iron source for food fortification. Bioavailability studies by means of the prophylactic-preventive method in rats. Biol Trace Elem Res. 2009 Feb;127(2):143-7. doi: 10.1007/s12011-008-8229-1. 

Abstract. The purpose of the present work was to evaluate the iron bioavailability of a new ferric pyrophosphate salt stabilized and solubilized with glycine. The prophylactic-preventive test in rats, using ferrous sulfate as the reference standard, was applied as the evaluating methodology both using water and yogurt as vehicles. Fifty female Sprague-Dawley rats weaned were randomized into five different groups (group 1: FeSO(4); group 2: pyr; group 3: FeSO(4) + yogurt; group 4: pyr + yogurt and group 5: control). The iron bioavailability (BioFe) of each compound was calculated using the formula proposed by Dutra-de-Oliveira et al. where BioFe % = (HbFef - HbFei) x 100/ToFeIn. Finally, the iron bioavailability results of each iron source were also given as relative biological value (RBV) using ferrous sulfate as the reference standard. The results showed that both BioFe % and RBV % of the new iron source tested is similar to that of the reference standard independently of the vehicle employed for the fortification procedure (FeSO(4) 49.46 +/- 12.0% and 100%; Pyr 52.66 +/- 15.02% and 106%; FeSO(4) + yogurth 54.39 +/- 13.92% and 110%; Pyr + yogurt 61.97 +/- 13.54% and 125%; Control 25.30 +/- 6.60, p < 0.05). Therefore, the stabilized and soluble ferric pyrophosphate may be considered as an optimal iron source for food fortification.